Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells
- 336 Downloads
Colorectal cancer (CRC) is one of the most frequently diagnosed malignancies. The generation of conventional treatments has improved, but approximately 50 % of patients with CRC who undergo potentially curative surgery ultimately relapse and die, usually as a consequence of metastatic disease. Our previous findings showed that engagement of the cellular prion protein (PrPC) to its ligand HSP70/90 heat shock organizing protein (HOP) induces proliferation of glioblastomas. In addition, PrPC has been described as an important modulator of colorectal tumor growth. Here, we investigated the biological relevance of the PrPC-HOP interaction in CRC cells. We demonstrate that HOP induced the migration and invasion of CRC cell lines in a PrPC-dependent manner and that phosphorylation of the ERK1/2 pathway is a downstream mediator of these effects. Additionally, we show that a HOP peptide with the ability to bind PrPC and abolish the PrPC-HOP interaction inhibited the migration and invasion of CRC cells. Together, these data indicate that the disruption of the PrPC-HOP complex could be a potential therapeutic target for modulating the migratory and invasive cellular properties that lead to metastatic CRC.
KeywordsPrion protein HOP protein Colorectal cancer Invasion Migration
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2009/14027‐2) and National Institute for Science and Technology in Oncogenomics (INCITO). TCSL (11/18718-0), FSG (12/23285-8), MVSD (10/19200-1), GPO (13/26097-0) and BLT (11/20853-2) received fellowships from FAPESP.
Compliance with ethical standards
Conflict of Interest
The authors declare no conflict of interest.
- 9.Lopes MH, Santos TG, Rodrigues BR, Queiroz-Hazarbassanov N, Cunha IW, Wasilewska-Sampaio AP et al (2014) Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival. Oncogene 34:3305–3314. doi: 10.1038/onc.2014.261 CrossRefPubMedGoogle Scholar
- 26.Soares IN, Caetano FA, Pinder J, Rodrigues BR, Beraldo FH, Ostapchenko VG et al (2013) Regulation of stress-inducible phosphoprotein 1 nuclear retention by protein inhibitor of activated STAT PIAS1. Mol Cell Proteomics 12:3253–3270. doi: 10.1074/mcp.M113.031005 CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Murray GI, Telfer CM, Melvin WT, inventors Markers for colorectal cancer. United States Patent Application Publication 2006; http://www.freepatentsonline.com/20060188883.pdf
- 44.Lopes MH, Hajj GN, Muras AG, Mancini GL, Castro RM, Ribeiro KC et al (2005) Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci 25:11330–11339. doi: 10.1523/JNEUROSCI.2313-05.2005 CrossRefPubMedGoogle Scholar
- 45.Santos TG, Beraldo FH, Hajj GN, Lopes MH, Roffe M, Lupinacci FC et al (2013) Laminin-γ1 chain and stress inducible protein 1 synergistically mediate PrPC-dependent axonal growth via Ca2+ mobilization in dorsal root ganglia neurons. J Neurochem 124:210–223. doi: 10.1111/jnc.12091 CrossRefPubMedGoogle Scholar